CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary Intervention

被引：9
|
作者：
Williams, Alexis K. [1 ]
Klein, Melissa D. [2 ]
Martin, Jesse [1 ]
Weck, Karen E. [4 ]
Rossi, Joseph S. [2 ,3 ]
Stouffer, George A. [2 ,3 ]
Lee, Craig R. [1 ,3 ]
机构：
[1] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Med, Div Cardiol, Chapel Hill, NC USA
[3] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA
[4] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA
来源：
CIRCULATION-GENOMIC AND PRECISION MEDICINE | 2019年 / 12卷 / 02期
关键词：
cardiovascular diseases; clopidogrel; pharmacogenetics; precision medicine; IMPLEMENTATION;
D O I：
10.1161/CIRCGEN.119.002441
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：97 / 99
页数：3
相关论文
共 50 条
  • [21] CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
    Tunehag, Kayla R.
    Thomas, Cameron D.
    Franchi, Francesco
    Rossi, Joseph S.
    Keeley, Ellen C.
    Anderson, R. David
    Beitelshees, Amber L.
    Duarte, Julio D.
    Gong, Yan
    Kerensky, Richard A.
    Mcdonough, Caitrin W.
    Nguyen, Anh B.
    Ortega-Paz, Luis
    Venkatesh, Sanjay
    Wang, Yehua
    Johnson, Julie A.
    Winterstein, Almut G.
    Stouffer, George A.
    Angiolillo, Dominick J.
    Cavallari, Larisa H.
    Lee, Craig R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (12):
  • [22] Economic Evaluations of CYP2C19 Genotype-Guided Antiplatelet Therapy Compared to the Universal Use of Antiplatelets in Patients With Acute Coronary Syndrome: A Systematic Review
    AlMukdad, Sawsan
    Elewa, Hazem
    Al-Badriyeh, Daoud
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (03) : 201 - 211
  • [23] Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
    Cavallari, Larisa H.
    Franchi, Francesco
    Rollini, Fabiana
    Been, Latonya
    Rivas, Andrea
    Agarwal, Malhar
    Smith, D. Max
    Newsom, Kimberly
    Gong, Yan
    Elsey, Amanda R.
    Starostik, Petr
    Johnson, Julie A.
    Angiolillo, Dominick J.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [24] Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
    Larisa H. Cavallari
    Francesco Franchi
    Fabiana Rollini
    Latonya Been
    Andrea Rivas
    Malhar Agarwal
    D. Max Smith
    Kimberly Newsom
    Yan Gong
    Amanda R. Elsey
    Petr Starostik
    Julie A. Johnson
    Dominick J. Angiolillo
    Journal of Translational Medicine, 16
  • [25] Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patients
    Lee, John Andrew
    Lee, Craig R.
    Reed, Brent N.
    Plitt, David C.
    Polasek, Melissa J.
    Howell, Lucius A.
    Cicci, Jonathan D.
    Tasca, Kristen E.
    Weck, Karen E.
    Rossi, Joseph S.
    Stouffer, George A.
    PHARMACOGENOMICS, 2015, 16 (04) : 303 - 313
  • [26] Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence
    Gower, Megan N.
    Ratner, Lindsay R.
    Williams, Alexis K.
    Rossi, Joseph S.
    Stouffer, George A.
    Lee, Craig R.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2020, 13 : 239 - 252
  • [27] Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
    Klein, Melissa D.
    Williams, Alexis K.
    Lee, Craig R.
    Stouffer, George A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (04) : 647 - 652
  • [28] Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China
    Zhang, Yi
    Shi, Xiu-Jin
    Peng, Wen-Xing
    Han, Jia-Lun
    Lin, Bai-Di
    Zhang, Ru
    Zhang, Yun-Nan
    Yan, Jia-Lin
    Wei, Juan-Juan
    Wang, Yi-Fan
    Chen, Su-Wei
    Nan, Nan
    Fang, Zhen-Wei
    Zeng, Yong
    Lin, Yang
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [29] Optimizing endovascular therapy for large vessel occlusion using CYP2C19 genotype-guided antiplatelet therapy: a case report
    Inui, Ryoma
    Ishiyama, Hiroyuki
    Abe, Soichiro
    Yoshimoto, Takeshi
    Fukumori, Junji
    Kushi, Yuji
    Imamura, Hirotoshi
    Kataoka, Hiroharu
    Ihara, Masafumi
    JOURNAL OF LABORATORY AND PRECISION MEDICINE, 2024, 9
  • [30] A case for genotype-guided de-escalation of antiplatelet therapy after percutaneous coronary angioplasty
    Cavallari, Larisa H.
    Lee, Craig R.
    FUTURE CARDIOLOGY, 2019, 15 (04) : 251 - 254
12345